Track 11 explores best practices in collaboration and information sharing that helps to drive progress in translational research. Case studies will be presented to show new insights on key drivers, technology innovations, collaboration platforms, open-source frameworks, and other factors that are managing analytical data and empowering transformative changes through translation. Additional topics to be covered include portals (website, research, collaboration) and their applications, data liquidity, and technical and cultural obstacles.
Download Brochure | Pre-
PANEL: Data Liquidity: New “Surge” in the War against Cancer, Diabetes and MS
Marcia Kean, Chairman, Strategic Initiatives, Feinstein Kean Healthcare
Gwen Darien, Executive Vice President, Programs and Services, Cancer Support Community
Robert McBurney, Ph.D., Neuroscientist and CEO, Accelerated Cure Project for MS
Kenneth Buetow, Ph.D., Director, Computational Sciences and Informatics, Complex Adaptive Systems Initiative (CASI), Arizona State University
Dave King, Founder and CEO, Exaptive, Inc.
Collaborating in Rare Diseases through Technology
Alex Sherman, Director, Strategic Development and Systems, Neurological Clinical Research Institute, Massachusetts General Hospital
Informatics Paradox: Separating and Collaborating in Life Science
Sarah Blendermann, Senior Director, Chemistry & Pharmacology, Business Technology, Pfizer
Towards the Intelligent and Automated Analytical Laboratory
Dave Hartsough, Ph.D., Executive Director, Research and Development Informatics, Amgen
Accelrys ScienceCloud: A Hosted Strategy for Collaborative R&D
Matt Hahn, Ph.D., CTO, Accelrys
PANEL: Forming a Collaborative Approach to Develop a Data and Technology Blueprint
Muzafar Mirza, Director, Information Strategy and Analytics, Clinical Informatics and Innovation, Pfizer, Inc.
Georgina Wood, Global Head, Technology Innovations, Novartis
Francis Kendall, Global Head, Statistical Programming and Analysis, Roche
Matt Smith, Director, Bristol Myers Squibb
Open PHACTS: Practical Semantics For Drug Discovery
Lee Harland, Ph.D., CTO, Open PHACTS, Connected Discovery
tranSMART: Enabling Rapid Exploratory Analyses and Hypothesis Generation at Pfizer
Peter V. Henstock, Ph.D., Statistics, Data Mining, and Visualization, Research Business Technology, Pfizer
Angela Gaudette, Business Analyst, Research Business Technology, Pfizer
The European Translational Research Information and Knowledge Management Services (eTRIKS): 18 Months into a Novel IMI Project to Support Translational Research Data Management
Jay Bergeron, Director, Translational and Bioinformatics, Pfizer
Interactive Medical Literature: ITN TrialShare for Open Access in Clinical Trials
Adam Asare, Ph.D., Senior Director Bioinformatics, ITN Bioinformatics, Immune Tolerance Network
Enable Unified Analysis and Mining of Biological and Chemical Data from Various Sources
Daniel Stoffler, Ph.D., Senior Principal Scientist, Group Leader Cheminformatics & Statistics, F. Hoffmann-La Roche Ltd.
Download Brochure | Pre-